Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

TRVI holding history

Trevi Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRVI overviewAll 13F holders of TRVIFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q1 2021
Holdings of TRVI by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,201,489−100.0%Sold outHolders
Q1 20261,201,489$14.3M<0.1%+1,048,634+686.0%AddedHolders
Q4 2025152,855$1.91M<0.1%+50,321+49.1%AddedHolders
Q3 2025102,534$938.2K<0.1%−1,216,732−92.2%ReducedHolders
Q2 20251,319,266$7.22M<0.1%+1,319,266NewHolders
Q1 20250$00.0%−1,233,176−100.0%Sold outHolders
Q4 20241,233,176$5.08M<0.1%+1,183,295+2,372.2%AddedHolders
Q3 202449,881$166.6K<0.1%+49,881NewHolders
Q2 20240$00.0%−28,680−100.0%Sold outHolders
Q1 202428,680$98.9K<0.1%−156,378−84.5%ReducedHolders
Q4 2023185,058$248.0K<0.1%+157,977+583.3%AddedHolders
Q3 202327,081$59.0K<0.1%−33,372−55.2%ReducedHolders
Q2 202360,453$144.5K<0.1%−11,202−15.6%ReducedHolders
Q1 202371,655$132.6K<0.1%+27,439+62.1%AddedHolders
Q4 202244,216$85.3K<0.1%+44,216NewHolders
Q1 20220$00.0%−49,849−100.0%Sold outHolders
Q4 202149,849$39.0K<0.1%+31,702+174.7%AddedHolders
Q3 202118,147$25.0K<0.1%+18,147NewHolders
Q2 20210$00.0%−10,617−100.0%Sold outHolders
Q1 202110,617$29.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.